Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
2023 | Green Cross Health Limited Declares an Interim Dividend, Payable on 20 December 2023 | CI |
2023 | Green Cross Health Limited Reports Earnings Results for the Half Year Ended September 30, 2023 | CI |
Sales 2022 | 67Cr 41Cr 3.4TCr | Sales 2023 | 49Cr 30Cr 2.51TCr | Capitalization | 19Cr 12Cr 981.96Cr |
---|---|---|---|---|---|
Net income 2022 | 2.4Cr 1.46Cr 121.84Cr | Net income 2023 | 4.5Cr 2.75Cr 228.44Cr | EV / Sales 2022 | 0.39 x |
Net Debt 2022 | 7.23Cr 4.41Cr 366.96Cr | Net Debt 2023 | 6.46Cr 3.94Cr 327.94Cr | EV / Sales 2023 | 0.52 x |
P/E ratio 2022 |
7.78
x | P/E ratio 2023 |
4.29
x | Employees | - |
Yield 2022 |
4.89% | Yield 2023 |
5.19% | Free-Float | 21.74% |
Managers | Title | Age | Since |
---|---|---|---|
Rachael Newfield
CEO | Chief Executive Officer | - | 30/18/30 |
Kalpana Goundar
DFI | Director of Finance/CFO | 40 | 04/12 |
Gary Safe
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Bagnall
BRD | Director/Board Member | - | 30/09/30 |
Kimmitt Ellis
CHM | Chairman | - | 02/19/02 |
Peter Merton
BRD | Director/Board Member | 61 | 30/09/30 |
1st Jan change | Capi. | |
---|---|---|
-5.75% | 935.85Cr | |
+30.58% | 132.51Cr | |
+5.08% | 28Cr | |
+12.22% | 23Cr | |
-41.07% | 9.42Cr | |
+19.73% | 5.93Cr |
- Stock Market
- Equities
- GXH Stock
- PRCXF Stock